A new study suggests that people taking a common type of blood pressure medication, known as Calcium Channel Blockers (CCBs), may have a higher risk of developing glaucoma. Glaucoma is a serious eye condition that can lead to vision loss if left untreated.
The research, led by Dr. Alan Kastner from Moorfields Eye Hospital and University College London, analyzed the medical records of 427,480 adults in the UK.
Among them, 33,175 were using CCBs to manage their blood pressure.
After accounting for factors like age, lifestyle, and other health conditions, the researchers found that people taking CCBs were more likely to be diagnosed with glaucoma compared to those not using these medications.
Interestingly, this link was not found with other types of blood pressure medication. The study also revealed that people on CCBs showed early signs of glaucoma-related eye changes, even though their eye pressure was normal.
Since glaucoma is usually linked to high eye pressure, this finding suggests that CCBs may be affecting the eyes in a different way that is not yet fully understood.
CCBs work by relaxing blood vessels, which improves blood flow and lowers blood pressure. While they are effective for heart health, this study raises concerns about their possible impact on the eyes.
Glaucoma develops slowly and often has no symptoms until significant vision loss occurs. Because of this, regular eye exams are crucial, especially for those at higher risk. Given that both high blood pressure and glaucoma can go unnoticed in the early stages, it’s important for people taking CCBs to be aware of potential eye health risks.
Dr. Kastner and his team stress that more research is needed to determine whether CCBs directly cause glaucoma or if another factor is involved.
In the meantime, people using CCBs should talk to their doctors about the study’s findings and discuss any concerns they have about their eye health. Balancing the benefits of blood pressure control with possible risks to vision is important.
Some researchers in the study have connections to pharmaceutical companies, but it is unclear if this influenced the results. The study has been published in JAMA Ophthalmology and provides valuable insights for both doctors and patients.
For now, staying informed and having regular eye check-ups can help people taking CCBs monitor their eye health and catch any potential problems early.
Copyright © 2025 Knowridge Science Report. All rights reserved.
